Qing Yuan Li
Director Financiero/CFO en CytoPharm, Inc. .
Perfil
Qing Yuan Li is currently the President, CFO, Director & IR Contact at CytoPharm, Inc. He previously worked as a Director at Merit Biotech, Inc. Dr. Li holds a doctorate degree from Colorado State University and an undergraduate degree from National Taiwan University.
Cargos activos de Qing Yuan Li
Empresas | Cargo | Inicio |
---|---|---|
CytoPharm, Inc.
CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Director Financiero/CFO | 22/09/2011 |
Antiguos cargos conocidos de Qing Yuan Li.
Empresas | Cargo | Fin |
---|---|---|
MERIT BIOTECH INC | Director/Miembro de la Junta | - |
Formación de Qing Yuan Li.
Colorado State University | Doctorate Degree |
National Taiwan University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
MERIT BIOTECH INC | Health Technology |
Empresas privadas | 1 |
---|---|
CytoPharm, Inc.
CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Health Technology |
- Bolsa de valores
- Insiders
- Qing Yuan Li